Home

Terumo Corp (TRUMF)

18.18
+0.00 (0.00%)
OP · Last Trade: Jun 12th, 5:47 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close18.18
Open-
Bid-
Ask-
Day's RangeN/A - N/A
52 Week Range15.00 - 22.26
Volume0
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume5,607

Chart

News & Press Releases

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analystbenzinga.com
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via Benzinga · January 23, 2024